Amro Aboukameel

4.0k total citations
91 papers, 2.8k citations indexed

About

Amro Aboukameel is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Amro Aboukameel has authored 91 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 46 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Amro Aboukameel's work include Cancer-related Molecular Pathways (21 papers), Nuclear Structure and Function (18 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Amro Aboukameel is often cited by papers focused on Cancer-related Molecular Pathways (21 papers), Nuclear Structure and Function (18 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Amro Aboukameel collaborates with scholars based in United States, Qatar and France. Amro Aboukameel's co-authors include Ramzi M. Mohammad, Asfar S. Azmi, Ayad Al‐Katib, Fazlul H. Sarkar, Philip A. Philip, Sanjeev Banerjee, Aamir Ahmad, Shaomeng Wang, Dejuan Kong and Irfana Muqbil and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Amro Aboukameel

91 papers receiving 2.7k citations

Peers

Countries citing papers authored by Amro Aboukameel

Since Specialization

Citations

This map shows the geographic impact of Amro Aboukameel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amro Aboukameel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amro Aboukameel more than expected).

Fields of papers citing papers by Amro Aboukameel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amro Aboukameel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amro Aboukameel. The network helps show where Amro Aboukameel may publish in the future.

Co-authorship network of co-authors of Amro Aboukameel

This figure shows the co-authorship network connecting the top 25 collaborators of Amro Aboukameel. A scholar is included among the top collaborators of Amro Aboukameel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amro Aboukameel. Amro Aboukameel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth 2024 ·Cancer Letters ·(unknown), Amro Aboukameel, Husain Yar Khan, Md. Hafiz Uddin, Hyejeong Jang, Eliza W. Beal, (unknown), Yang Shi, Seongho Kim, Kay‐Uwe Wagner, (unknown), Bassel F. El‐Rayes, Philip A. Philip, Ramzi M. Mohammad, Muhammad Wasif Saif, Mohammed Najeeb Al Hallak, Boris Pasche, Asfar S. Azmi	2
2	Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia 2024 ·Blood ·(unknown), Md. Hafiz Uddin, (unknown), (unknown), Amro Aboukameel, Husain Yar Khan, (unknown), Jay Yang, Gregory Dyson, Steven Buck, Asfar S. Azmi, Lisa Polin, Francis Burrows, Linda Kessler, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian	2
3	Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers 2023 ·Molecular Cancer Therapeutics ·Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, (unknown), Md. Hafiz Uddin, (unknown), (unknown), Ibrahim Azar, Eliza W. Beal, (unknown), Steve Kim, (unknown), Erkan Baloglu, William Senapedis, Bassel F. El‐Rayes, Philip A. Philip, Ramzi M. Mohammad, Anthony F. Shields, Mohammed Najeeb Al Hallak, Asfar S. Azmi	5
4	A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic adenocarcinoma. 2023 ·Journal of Clinical Oncology ·Mandana Kamgar, Husain Yar Khan, Amro Aboukameel, (unknown), Brian Y. Chung, Anikó Szabó, Yiwei Li, Mohammed Najeeb Al Hallak, (unknown), Ben George, Kathleen K. Christians, Douglas B. Evans, Susan Tsai, Beth Erickson, (unknown), Asfar S. Azmi, William A. Hall	1
5	Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers 2022 ·Cancer Research Communications ·Husain Yar Khan, Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton, (unknown), (unknown), Mohammed Najeeb Al Hallak, Steve Kim, (unknown), Yosef Landesman, Hirva Mamdani, Dipesh Uprety, Philip A. Philip, Ramzi M. Mohammad, Anthony F. Shields, Asfar S. Azmi	21
6	Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy 2022 ·Advances in Radiation Oncology ·Husain Yar Khan, Mandana Kamgar, Amro Aboukameel, (unknown), Brian Y. Chung, Yiwei Li, Mohammed Najeeb Al Hallak, Philip A. Philip, Susan Tsai, (unknown), William A. Hall, Asfar S. Azmi	13
7	PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus 2021 ·Molecular Cancer Therapeutics ·(unknown), Md. Hafiz Uddin, Mohammed Najeeb Al Hallak, Amro Aboukameel, Yiwei Li, Steve Kim, (unknown), Gregory Dyson, Erkan Baloglu, William Senapedis, Yosef Landesman, Kay‐Uwe Wagner, Nerissa T. Viola, Bassel F. El‐Rayes, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi	16
8	Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth 2020 ·Cancers ·Husain Yar Khan, (unknown), Rachel Sexton, Srikant Viswanadha, (unknown), Amro Aboukameel, Maria Diab, Mandana Kamgar, Mohammed Najeeb Al Hallak, (unknown), Anteneh Tesfaye, Steve Kim, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi	28
9	Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma 2019 ·Clinical Cancer Research ·Asfar S. Azmi, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Jasper E. Neggers, Dirk Daelemans, Amit Mahipal, Gregory Dyson, Mandana Kamgar, Mohammed Najeeb Al Hallak, Anteneh Tesfaye, Steve Kim, Vinod B. Shidham, Ramzi M. Mohammad, Philip A. Philip	40
10	Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance 2019 ·International Journal of Molecular Sciences ·Husain Yar Khan, (unknown), Misako Nagasaka, Amro Aboukameel, (unknown), Irfana Muqbil, (unknown), (unknown), Erkan Baloglu, Yosef Landesman, Ramzi M. Mohammad, Asfar S. Azmi, Ammar Sukari	30
11	PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors 2019 ·Cancers ·(unknown), Amro Aboukameel, Irfana Muqbil, Steve Kim, (unknown), Philip A. Philip, Ramzi M. Mohammad, Mandana Kamgar, Vinod B. Shidham, William Senapedis, Erkan Baloglu, Jing Li, Gregory Dyson, Yue Xue, Bassel F. El‐Rayes, Asfar S. Azmi	24
12	Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma 2016 ·Molecular Cancer Therapeutics ·Amro Aboukameel, Irfana Muqbil, William Senapedis, Erkan Baloglu, Yosef Landesman, Sharon Shacham, Michael Kauffman, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi	74
13	Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition 2015 ·Scientific Reports ·Asfar S. Azmi, Irfana Muqbil, Jack Wu, Amro Aboukameel, William Senapedis, Erkan Baloglu, Aliccia Bollig‐Fischer, Gregory Dyson, Michael Kauffman, Yosef Landesman, Sharon Shacham, Philip A. Philip, Ramzi M. Mohammad	29
14	A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo 2013 ·Molecular Cancer Therapeutics ·Fardokht A. Abulwerdi, Chenzhong Liao, Meilan Liu, Asfar S. Azmi, Amro Aboukameel, Ahmed S.A. Mady, Thippeswamy Gulappa, Tomasz Cierpicki, Scott R. Owens, Tao Zhang, Duxin Sun, Jeanne A. Stuckey, Ramzi M. Mohammad, Zaneta Nikolovska‐Coleska	158
15	ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells 2010 ·Molecular Cancer Therapeutics ·Jyoti Nautiyal, Yingjie Yu, Amro Aboukameel, Shailender S. Kanwar, Jayanta Das, Jianhua Du, Bhaumik B. Patel, Fazlul H. Sarkar, Arun K. Rishi, Ramzi M. Mohammad, Adhip P.N. Majumdar	9
16	Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy 2010 ·Current Cancer Drug Targets ·Asfar S. Azmi, P. A. Philip, Amro Aboukameel, (unknown), (unknown), Syed F. Zafar, Anton Scott Goustin, Khaldoun Almhanna, Dajun Yang, F. H. Sarkar, Ramzi M. Mohammad	40
17	Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor 2010 ·Cancer Chemotherapy and Pharmacology ·Edi Levi, Liyue Zhang, Amro Aboukameel, (unknown), Ramzi M. Mohammad, Lisa Polin, James S. Hatfield, Arun K. Rishi	4
18	SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status 2009 ·Journal of Hematology & Oncology ·Ayad Al‐Katib, Yuan Sun, Anton Scott Goustin, Asfar S. Azmi, Ben Chen, Amro Aboukameel, Ramzi M. Mohammad	26
19	Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model 2008 ·Molecular Cancer ·(unknown), Amro Aboukameel, Jianyong Chen, Dajun Yang, Shaomeng Wang, Ayad Al‐Katib, Ramzi M. Mohammad	70
20	The Inactive 44-kDa Processed Form of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Enhances Proteolytic Activity via Regulation of Endocytosis of Active MT1-MMP 2008 ·Journal of Biological Chemistry ·(unknown), Pamela Osenkowski, Huiren Zhao, (unknown), Márta Tóth, Kristina A. Cole, Amro Aboukameel, Allen Saliganan, Lucia Schuger, R. Daniel Bonfil, Rafael Fridman	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact